Butler, C. C., Yu, L., Dorward, J., Gbinigie, O., Hayward, G., Saville, B. R., . . . Hobbs, F. D. R. (2021). Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med.
Styl cytowania ChicagoButler, Christopher C., et al. "Doxycycline for Community Treatment of Suspected COVID-19 in People At High Risk of Adverse Outcomes in the UK (PRINCIPLE): A Randomised, Controlled, Open-label, Adaptive Platform Trial." Lancet Respir Med 2021.
Styl cytowania MLAButler, Christopher C., et al. "Doxycycline for Community Treatment of Suspected COVID-19 in People At High Risk of Adverse Outcomes in the UK (PRINCIPLE): A Randomised, Controlled, Open-label, Adaptive Platform Trial." Lancet Respir Med 2021.